Longevity Health Holdings, Inc. Warrant
XAGEW
XAGEW was delisted on the 11th of September, 2025.
16 hedge funds and large institutions have $172K invested in Longevity Health Holdings, Inc. Warrant in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 16 → 16 (0)
1% less capital invested
Capital invested by funds: $174K → $172K (-$2.54K)
1.17% less ownership
Funds ownership: 10.89% → 9.72% (-1.2%)
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$738 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Exos Asset Management
New York
|
-$6.51K |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$334 |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$98 |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$65 |
XAGEW Hedge Fund Activity: Q3 2024 in Review
16 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Warrant (XAGEW) for Q3 2024, worth a combined $172K — down 1.5% from $174K a quarter earlier.
Fund positioning in XAGEW was balanced in Q3 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 4 trimmed.
The largest buyer was UBS Group, adding an estimated $738. The largest seller was Exos Asset Management, cutting an estimated $6.51K.
- 16 institutional investors held Longevity Health Holdings, Inc. Warrant (XAGEW) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $172K of Longevity Health Holdings, Inc. Warrant stock for Q3 2024, down 1.5% quarter-over-quarter.
- 0 funds opened new Longevity Health Holdings, Inc. Warrant positions in Q3 2024 and 0 closed out.
- The largest Longevity Health Holdings, Inc. Warrant buyer in Q3 2024 was UBS Group, an estimated $738 added.
- The largest Longevity Health Holdings, Inc. Warrant seller in Q3 2024 was Exos Asset Management, an estimated $6.51K sold.
Based on aggregated 13F filings for Q3 2024.